Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

350
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
350
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

175
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
175
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

201
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

218
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
218
Hazard Ratio01:12

Hazard Ratio

299
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
299
Contingency Table01:29

Contingency Table

2.8K
A contingency table provides a way of portraying data that can facilitate calculating probabilities. It is a method of displaying a frequency distribution as a table with rows and columns to show how two variables may be dependent (contingent) upon each other; The table helps determine conditional probabilities quite quickly and can help systematically organize, analyze and quantify data. The table displays sample values concerning two variables that may be dependent or contingent on one...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Blood advances·2026
Same author

Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

bioRxiv : the preprint server for biology·2026
Same author

Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Blood·2026
Same author

A High-Fiber, Plant-Based Diet in Myeloma Precursor Disorders: Results from the NUTRIVENTION Clinical Trial and Preclinical Vk*MYC Model.

Cancer discovery·2025
Same author

Exploring the heterogeneity in recurrent episode lengths based on quantile regression.

Biometrics·2025
Same author

Kit<sup>lo</sup> hematopoietic stem cells exhibit distinct lymphoid-primed chromatin landscapes that enhance thymic reconstitution.

Nature communications·2025

Related Experiment Video

Updated: Oct 19, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Evaluating the association between latent classes and competing risks outcomes with multiphenotype data.

Teng Fei1, John Hanfelt2, Limin Peng2

  • 1Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Biometrics
|September 17, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical model for analyzing disease heterogeneity in mild cognitive impairment (MCI) patients. The method links latent classes of one condition to risks of another, accounting for complex data issues.

Keywords:
competing riskscumulative incidence functionestimating equationlatent class analysisstructural model

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.2K

Related Experiment Videos

Last Updated: Oct 19, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.2K

Area of Science:

  • Statistics
  • Biostatistics
  • Epidemiology

Background:

  • Latent class analysis is key for understanding disease heterogeneity.
  • Investigating associations between latent classes across different phenotypes is increasingly important in chronic disease research.
  • Mild cognitive impairment (MCI) studies often involve complex data with multiple phenotypes.

Purpose of the Study:

  • To propose and evaluate a time-dependent structural model for assessing the relationship between latent classes and competing risk outcomes.
  • To address challenges in analyzing competing risks data, including random censoring and missing failure types.
  • To develop a robust statistical framework applicable to real-world cohort data, such as the Uniform Data Set (UDS).

Main Methods:

  • A novel two-step estimation procedure is developed, avoiding direct latent class assignment and accounting for classification uncertainty.
  • The method incorporates a time-dependent structural model to analyze associations between latent classes and competing risks.
  • Analytical inference procedures are developed to overcome limitations of standard bootstrapping in this context.

Main Results:

  • The proposed method rigorously accounts for uncertainty in latent class assignment.
  • It effectively handles competing risks outcomes with random censoring and missing failure types.
  • Simulation studies confirm the method's advantages over existing approaches.

Conclusions:

  • The developed statistical model provides a robust approach for analyzing phenotype heterogeneity and its association with competing risks.
  • The method offers a practical and analytically tractable solution for complex longitudinal data in chronic disease research.
  • Application to MCI data reveals significant neuropathological insights into baseline MCI subgroups.